Bill 7 — An Act To Amend the Pharmaceutical Association Act, 1994 (44th General Assembly, 2nd Session)
Bill 7
Newfoundland and Labrador — Bills
Second Session, 44th General Assembly
49 Elizabeth II, 2000
BILL 7
AN ACT TO AMEND THE
PHARMACEUTICAL
ASSOCIATION ACT, 1994
Received and Read the First
Time
Second Reading
Committee
Third Reading
Royal Assent
HONOURABLE ROGER GRIMES
Minister of Health and Community Services
Ordered to be printed by the
Honourable House of Assembly
EXPLANATORY NOTES
This Bill would amend the Pharmaceutical
Association Act, 1994 to provide for pharmacist participation in
the prescription drug monitoring program established under the
Medical Act .
The Bill would further indemnify a pharmacist who
complies with a request for information under the program from
liability for providing that information to the program.
A BILL
AN ACT TO AMEND THE PHARMACEUTICAL ASSOCIATION
ACT, 1994
Analysis
1. S.34.1 Added
Compliance with prescription drug monitoring program
Be it enacted by the
Lieutenant-Governor and House of Assembly in Legislative
Session convened, as follows:
SN1994 cP-12.1
1. The Pharmaceutical Association Act, 1994 is
amended by adding immediately after
section 34 the following:
Compliance with prescription drug monitoring program
34.1
(1) A pharmacist shall, where the
Newfoundland Medical Board or a person authorized by that board
requests under the prescription drug monitoring program established
section 24.16 of the Medical Act, provide the information
that the Newfoundland Medical Board or a person authorized by that
board requests.
(2) The information requested under subsection
(1) may include but is not limited to patient records, notes,
accounts and other documents kept by the pharmacist.
(3) A pharmacist who fails to comply with a
request under subsection (1) is guilty of professional misconduct.
(4) An action for damages does not lie against a
pharmacist solely because the pharmacist provides the information
requested of him or her under subsection (1).
(5) A pharmacist is not guilty of professional
misconduct solely because the pharmacist provides the information
requested of him or her under subsection (1).
Earl G. Tucker, Queen's Printer